Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Every infusion protocol starts with a lab panel so we know exactly what your body needs
6 , eabc4824 (2020)
The average listed price in the U.S
Science (2010) 327(5966):65661
CEO Brian Lian framed the differentiation as the only dual agonist molecule with the potential to dose monthly or to allow transition from subcutaneous to oral administration for weight maintenance. Risk: Viking is pre-revenue, with a 2025 net loss of $359.64 million and a cash position that fell from $903 million at the start of 2025 to $706 million at year-end
US$ 21.29
US$ 22.61
US$ 26.13
US$ 21.23
US$ 29.44
US$ 22.71
US$ 24.74
US$ 24.07
US$ 26.51
